Reduced dose versus standard melphalan conditioning for autologous stem cell transplantation in multiple myeloma: a single-center retrospective study

Abstract This retrospective, single‑center study evaluated the efficacy and safety of a reduced‑dose melphalan conditioning regimen (140–180 mg/m2) for autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM) ineligible for the standard dose (200 mg/m2). Clinical outcomes w...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yifan Yao, Shan Zhang, Ziying Li, Lili Luo, Xuan Lu, Huafang Wang
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Springer 2026-03-01
Colección:	Annals of Hematology
Materias:	Multiple myeloma Autologous stem cell transplantation Melphalan Dose reduction
Acceso en línea:	https://doi.org/10.1007/s00277-026-06909-1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!